Shares in Cardica (CRDC) fell of a cliff yesterday as an A.G. Edwards analyst downgraded the stock on muted enthusiasm for its new surgical product. The fellow must feel a bit embarrassed today.

CRDC shares are up over 20% today on news the company "received a key European approval for its new device for connecting blood vessels during heart bypass surgery," according to The Associated Press.

So there.

Douglas A. McIntyre